Results 41 to 50 of about 212,589 (324)

Nurses knowledge and practice towards prevention on deep vein thrombosis in University of Gondar Comprehensive Specialized Hospital, northwest Ethiopia

open access: yesInternational Journal of Africa Nursing Sciences, 2021
Introduction: Deep vein thrombosis is a common problem among people who are immobile for a long period of time. Although it is preventable, it is still one of the problems of the people related to poor knowledge and practice of nurses on Deep Vein ...
Nurhusien Nuru Yesuf   +6 more
doaj  

Deep vein thrombosis: pathogenesis, diagnosis, and medical management.

open access: yesCardiovascular Diagnosis and Therapy, 2017
Deep vein thrombosis (DVT) is a major preventable cause of morbidity and mortality worldwide. Venous thromboembolism (VTE), which includes DVT and pulmonary embolism (PE), affects an estimated 1 per 1,000 people and contributes to 60,000-100,000 deaths ...
J. Stone   +7 more
semanticscholar   +1 more source

Inflammation in deep vein thrombosis: a therapeutic target?

open access: yesHematology, 2019
Deep vein thrombosis is a common disease associated with a variety of complications including post-thrombotic syndrome as a late complication. It is now clear that in addition to classical deep vein thrombosis triggers such as blood flow disturbance ...
D. Borgel   +4 more
semanticscholar   +1 more source

Flow‐Induced Vascular Remodeling on‐Chip: Implications for Anti‐VEGF Therapy

open access: yesAdvanced Functional Materials, EarlyView.
Flow‐induced vascular remodeling plays a critical role in network stabilization and function. Using a vasculature‐on‐chip system, this study reveals how physiological VEGF levels and flow affect vascular remodeling and provides insights into tumor vessel normalization.
Fatemeh Mirzapour‐Shafiyi   +6 more
wiley   +1 more source

Treatment of distal deep vein thrombosis.

open access: yesCochrane Database of Systematic Reviews, 2019
BACKGROUND The treatment of distal (below the knee) deep vein thrombosis (DVT) is not clearly established. Distal DVT can either be treated with anticoagulation, or monitored with close follow-up to detect progression to the proximal veins (above the ...
G. Kirkilesis   +4 more
semanticscholar   +1 more source

Bioengineering Strategies for Treating Neointimal Hyperplasia in Peripheral Vasculature: Innovations and Challenges

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
This review highlights emerging bioengineering strategies for treating neointimal hyperplasia in the peripheral vasculature, focusing on approaches that promote re‐endothelialization, modulate smooth muscle cell phenotype, reduce inflammation, mitigate oxidative stress, and optimize biomechanical compliance.
Nikita Wilson John   +5 more
wiley   +1 more source

Primary Iliac Venous Leiomyosarcoma: A Rare Cause of Deep Vein Thrombosis in a Young Patient

open access: yesCase Reports in Medicine, 2011
Introduction. Primary venous tumours are a rare cause of deep vein thrombosis. The authors present a case where the definitive diagnosis was delayed by inconclusive complementary imaging. Clinical Case.
Nelson Oliveira   +4 more
doaj   +1 more source

Deep Vein Thrombosis in Children

open access: yesPediatric Reports, 2013
We describe a rare case of deep vein thrombosis (DVT) in children, highlight the importance of early diagnosis of rare disease with potential complications. In a 5 year old boy presented with persistent leg pain without any obvious cause. Detailed investigation led to diagnosis of DVT. As there are common differential diagnoses for leg pain in children,
Aabideen, Kanakkande   +3 more
openaire   +5 more sources

Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.

open access: yesBlood, 2017
Deep vein thrombosis (DVT) with its major complication, pulmonary embolism, is a global health problem. Mechanisms of DVT remain incompletely understood.
Holly Payne   +3 more
semanticscholar   +1 more source

Bioprinted Micro‐Clots for Kinetic Analysis of Endothelial Cell‐Mediated Fibrinolysis

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
This paper describes the development of a microscale model that quantifies the breakdown of fibrin by endothelial cells. The small size scale of this engineered system enables fibrin breakdown to be observed without the addition of external activators. This system could help in identifying compounds which both promote and hinder thrombosis.
Jonathan J. Chang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy